HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


E’Ola Ephedrine Hydrochloride Sales Barred Under FDA Settlement

This article was originally published in The Tan Sheet

Executive Summary

FDA may order Biogenics, d/b/a E'Ola International, to "discontinue all manufacturing, processing, packing, labeling and distribution" if it believes the supplement marketer is selling a misbranded or adulterated product, according to a recent consent decree

You may also be interested in...

GMP Dispute Resolution System Under Development By FDA; PAT Is Impetus

FDA is planning to create a dispute resolution system for manufacturing inspections

E’Ola Ephedrine HCl Product Seized, FDA Complaint Alleges Item To Be Drug

Approximately 140,000 bottles of E'Ola International's AMP II Pro Drops, worth roughly $2.8 mil., were seized by U.S. Marshals Oct. 31

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts